Researchers reported the first isolation of M. saskatchewanense from medical-grade equipment.
FDA addresses expanded use of data monitoring committees in draft guidance
The FDA laid out considerations for how sponsors should leverage committees to help analyze clinical trial data in draft guidance published Monday. The draft arrives